The Russian government has announced a potentially groundbreaking development in cancer treatment, the creation of mRNA (messenger RNA)--based vaccines designed to combat Cancer. This announcement was made by the state-run Russian news agency TASS.
The General Director of the Radiology Medical Research Centre of the Russian Ministry of Health, Andrey Kaprin, says this groundbreaking development of mRNA-based personalized cancer vaccines is set to be distributed to cancer patients free of cost and the state from 2025 onwards with approximately 300,000 rubles (USD 2,869).
This vaccine has been developed in collaboration with various Russian scientists and researchers, and the preclinical trial shows that the mRNA-based vaccine aims to suppress the development of potential tumors and metastases, says Alexander Ginsburg, Director of the Gamaleya National Research Centre.
How does the mRNA-based cancer vaccine work?
Russian President Vladimir Putin earlier this year made statements such as claiming that ‘we have come very close to the creation of the so-called development of a vaccine to treat cancer.’.
Alexander Ginsberg, Director of the Gamaleya National Research Centre sheds light on the procedure of producing mRNA vaccine, the use of artificial neural networks could bring down the time required for creating personalized vaccines via computing, which could be brought down to less than an hour in duration.
Russia's vaccine chief says, Now it’s quite a lengthy process to build a (personalized vaccine) because computing how a customized mRNA should look like uses the matrix method in mathematical terms. We have involved the Ivannikov Institute, which will rely on AI in doing the math, namely neural network computing, where the procedure should take about an hour or so”.
The Role of Vaccines in Cancer Management
The Russian government, to protect its population from various forms of cancer, has taken a revolutionary stand by developing mRNA-based personalized cancer vaccines.
As per the case report published in 2022, new cases of over 635,000 approximately reports have been registered with the steady rise of cancer patients in the form of breast, colon, and lung cancer being among the most common types of cancer.
Various countries have attempted numerous studies and research on curing cancer and creating effective vaccines. Such as, in the United States, the University of Florida has recently tested an individualized vaccine on patients with glioblastoma, a form of brain cancer; the vaccine shows promising reports of the creation of robust immune responses within two days of injection.
In the UK, scientists have developed a personalized vaccine for melanoma, the deadliest form of skin cancer, which shows promising results and indicates the highest survival rates.
With inputs from agencies
Image Source: PTI
*The views expressed are personal to the author and do not reflect the platform's opinion of the same.
© Copyright 2024. All Rights Reserved Powered by Vygr Media.
Author's Bio
Neha Kumari is a student of Sociology pursuing her postgraduate degree from University of North Bengal. A passionate writer, she has collaborated with various notable NGOs, with her impactful writing and journalism she aims to advocate for social change
